405 related articles for article (PubMed ID: 36200122)
1. Polycystic Liver Disease: Pathophysiology, Diagnosis and Treatment.
Norcia LF; Watanabe EM; Hamamoto Filho PT; Hasimoto CN; Pelafsky L; de Oliveira WK; Sassaki LY
Hepat Med; 2022; 14():135-161. PubMed ID: 36200122
[TBL] [Abstract][Full Text] [Related]
2. Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management.
Cnossen WR; Drenth JP
Orphanet J Rare Dis; 2014 May; 9():69. PubMed ID: 24886261
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of polycystic liver disease.
Gevers TJ; Drenth JP
Nat Rev Gastroenterol Hepatol; 2013 Feb; 10(2):101-8. PubMed ID: 23296249
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology, epidemiology, classification and treatment options for polycystic liver diseases.
Abu-Wasel B; Walsh C; Keough V; Molinari M
World J Gastroenterol; 2013 Sep; 19(35):5775-86. PubMed ID: 24124322
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation for polycystic liver disease.
Pirenne J; Aerts R; Yoong K; Gunson B; Koshiba T; Fourneau I; Mayer D; Buckels J; Mirza D; Roskams T; Elias E; Nevens F; Fevery J; McMaster P
Liver Transpl; 2001 Mar; 7(3):238-45. PubMed ID: 11244166
[TBL] [Abstract][Full Text] [Related]
6. Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management.
Zhang ZY; Wang ZM; Huang Y
World J Hepatol; 2020 Mar; 12(3):72-83. PubMed ID: 32231761
[TBL] [Abstract][Full Text] [Related]
7. Treatment of polycystic liver disease. Update on the management.
Aussilhou B; Dokmak S; Dondero F; Joly D; Durand F; Soubrane O; Belghiti J
J Visc Surg; 2018 Dec; 155(6):471-481. PubMed ID: 30145049
[TBL] [Abstract][Full Text] [Related]
8. Young women with polycystic liver disease respond best to somatostatin analogues: a pooled analysis of individual patient data.
Gevers TJ; Inthout J; Caroli A; Ruggenenti P; Hogan MC; Torres VE; Nevens F; Drenth JP
Gastroenterology; 2013 Aug; 145(2):357-65.e1-2. PubMed ID: 23665274
[TBL] [Abstract][Full Text] [Related]
9. An update on the pathophysiology and management of polycystic liver disease.
Wong MY; McCaughan GW; Strasser SI
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):569-581. PubMed ID: 28317394
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life.
Duijzer R; Barten TRM; Staring CB; Drenth JPH; Gevers TJG
J Clin Gastroenterol; 2022 Oct; 56(9):731-739. PubMed ID: 35997709
[TBL] [Abstract][Full Text] [Related]
11. New Advances in Polycystic Liver Diseases.
Santos-Laso A; Izquierdo-Sánchez L; Lee-Law PY; Perugorria MJ; Marzioni M; Marin JJ; Bujanda L; Banales JM
Semin Liver Dis; 2017 Feb; 37(1):45-55. PubMed ID: 28201848
[TBL] [Abstract][Full Text] [Related]
12. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease.
Barten TRM; Bernts LHP; Drenth JPH; Gevers TJG
Expert Opin Ther Targets; 2020 Jun; 24(6):589-599. PubMed ID: 32250187
[No Abstract] [Full Text] [Related]
13. [Polycystic liver disease].
Ongaro M; Bronstein FN; Goossens N; Spahr L; Bresson Hadni S
Rev Med Suisse; 2022 Aug; 18(793):1599-1605. PubMed ID: 36047551
[TBL] [Abstract][Full Text] [Related]
14. Liver involvement in early autosomal-dominant polycystic kidney disease.
Hogan MC; Abebe K; Torres VE; Chapman AB; Bae KT; Tao C; Sun H; Perrone RD; Steinman TI; Braun W; Winklhofer FT; Miskulin DC; Rahbari-Oskoui F; Brosnahan G; Masoumi A; Karpov IO; Spillane S; Flessner M; Moore CG; Schrier RW
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):155-64.e6. PubMed ID: 25111236
[TBL] [Abstract][Full Text] [Related]
15. Polycystic liver disease: a clinical review.
Chandok N
Ann Hepatol; 2012; 11(6):819-26. PubMed ID: 23109444
[TBL] [Abstract][Full Text] [Related]
16. Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation.
Schnelldorfer T; Torres VE; Zakaria S; Rosen CB; Nagorney DM
Ann Surg; 2009 Jul; 250(1):112-8. PubMed ID: 19561475
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targets in Polycystic Liver Disease.
Masyuk TV; Masyuk AI; LaRusso NF
Curr Drug Targets; 2017; 18(8):950-957. PubMed ID: 25915482
[TBL] [Abstract][Full Text] [Related]
18. Questionnaire PLD-complaint-specific assessment identifies need for therapy in polycystic liver disease: A multi-centric prospective study.
Billiet A; Temmerman F; Coudyzer W; Van den Ende N; Colle I; Francque S; De Maeght S; Janssens F; Orlent H; Sprengers D; Delwaide J; Decock S; De Vloo C; Moreno C; van Malenstein H; van der Merwe S; Verbeek J; Nevens F
United European Gastroenterol J; 2023 Sep; 11(7):633-641. PubMed ID: 37278135
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-mediated reduction of miR-345 contributes to hepatic cystogenesis in polycystic liver disease.
Masyuk T; Masyuk A; Trussoni C; Howard B; Ding J; Huang B; LaRusso N
JHEP Rep; 2021 Oct; 3(5):100345. PubMed ID: 34568801
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
